GCT Semiconductor (GCTS) Q2 2024 earnings summary

Executive summary

• Net revenues for Q2 2024 fell to $1.5 million, down from $4.3 million year-over-year, as the company transitions from 4G to 5G chip sales, with 5G initial deliveries to alpha customers expected in Q4 2024 and volume ramp in 2025.

• Announced major partnerships with Samsung and Kyocera to accelerate 4G/5G development and commercialization, including a 5G millimeter wave reference platform and Band 54 modules launch.

• Completed a reverse recapitalization and PIPE financing, raising $17.2 million and transitioning to a public company structure as of March 26, 2024.

• Included in the Russell 2000 Index, reflecting increased market visibility.

• Operations are global, with R&D in South Korea and sales/marketing in the US, China, Taiwan, and Japan.

Financial highlights

• Net revenue for Q2 2024 was $1.5 million, down 66% year-over-year, mainly due to a $4.0 million drop in product sales, partially offset by higher service revenue.

• Gross margin declined to 63% from 66% year-over-year, mainly due to lower product sales.

• Net loss for Q2 2024 was $1.0 million, a significant improvement from a $6.6 million net loss in Q2 2023, aided by a $6.9 million gain in other income.

• Operating expenses for Q2 2024 increased 9% year-over-year to $8.0 million, driven by higher R&D and public company costs.

• Cash and cash equivalents stood at $4.0 million as of June 30, 2024.

Outlook and guidance

• 5G chipset sampling to multiple alpha customers in Q4 2024, with volume ramp anticipated in 2025.

• Management expects net revenues to increase with the launch of 5G products and normalization of customer inventory levels.

• Service revenue expected to remain flat through Q4, with potential upside from new MOUs.

• Sufficient liquidity is expected for at least 12 months, but long-term funding will require positive cash flow, debt renegotiation, or additional capital raises.

• Significant expenditures are anticipated for 5G product commercialization in 2025.